Speakers

Expand/Collapse

Ed Ha
Head of Chemistry & Bioconjugation
Angiex

Day Two

Thursday 1st July 2021

2:05 pm | Live Presenter Q&A

2:15 pm | Panel Discussion: Small Molecule vs Biologics in Induced Proximity

1:40 pm | How ADC Hunters Investigate Induced Proximity

Nancy Pryer
Chief Scientific Officer
Ambagon Therapeutics

Day One

Wednesday 30th June 2021

9:00 am | Panel Discussion: Advancing the Discovery of Proximity-Based Medicines

Ryan Potts
Executive Director & Head of Induced Proximity Platform
Amgen

Day Two

Thursday 1st July 2021

2:15 pm | Panel Discussion: Small Molecule vs Biologics in Induced Proximity

Derek J. Taylor
Associate Professor
Case Western Reserve University

Benjamin Stanton
Principal Investigator
Abigail Wexner Research Institute at Nationwide Children’s Hospital

Day One

Wednesday 30th June 2021

12:20 pm | Live Presenter Q&A

11:30 am | Chemically Induced Proximity in Biology and Medicine

Stuart L. Schreiber
Co-Founder
Broad Institute

Day One

Wednesday 30th June 2021

10:00 am | 30 Years of Molecular Glues: Controlling Cell Circuitry in Biology and Medicine

Katelyn Cassidy
Senior Scientist
AstraZeneca

Eric Wang
Research Fellow
Dana-Farber Cancer Institute

Day Two

Thursday 1st July 2021

5:10 pm | Live Presenter Q&A

4:45 pm | Structure Based Design of Degraders

Radoslaw Nowak
Scientist
Dana-Farber Cancer Institute

Day Two

Thursday 1st July 2021

5:10 pm | Live Presenter Q&A

4:45 pm | Structure Based Design of Degraders

Charles Lin
Senior Vice President – Biology
Kronos Bio

Day One

Wednesday 30th June 2021

9:00 am | Panel Discussion: Advancing the Discovery of Proximity-Based Medicines

Jamie Kasuboski
Vice President
OMX Ventures

Day One

Wednesday 30th June 2021

12:20 pm | Live Presenter Q&A

11:55 am | Induced Proximity: An Investors Perspective

Cristina Mayor- Ruiz
Group Leader
IRB Barcelona

Day One

Wednesday 30th June 2021

2:45 pm | Live Presenter Q&A

1:40 pm | Strategies to Discover Molecular Glue Degraders at Scale

Jonathan Solomon
Associate Director
Novartis Institutes for Biomedical Research

Day Two

Thursday 1st July 2021

11:25 am | Discovery of a VHL-binding Molecular Glue Degrader

11:50 am | Live Presenter Q&A

Matthias Brand
VP Biology
Proxygen

Day One

Wednesday 30th June 2021

2:45 pm | Live Presenter Q&A

2:05 pm | Scalable Discovery and Streamlined Characterization of Novel Molecular Glue Degraders

Chad May
Senior Vice President, R&D
Maverick Therapeutics

Day Two

Thursday 1st July 2021

2:05 pm | Live Presenter Q&A

2:15 pm | Panel Discussion: Small Molecule vs Biologics in Induced Proximity

1:15 pm | Bispecific T Cell Engagers Designed to Redirect Effector Function

Goutham Narla
Professor of Medicine
University of Michigan

Day Two

Thursday 1st July 2021

5:20 pm | Chair’s Closing Remarks & End of Conference

11:50 am | Live Presenter Q&A

11:00 am | Biased and Selective Small Molecule Mediated Activation of Protein Phosphatase 2A

8:55 am | Chair’s Opening Remarks

Daniel Nomura
Professor of Chemical Biology
University of California, Berkeley

Day One

Wednesday 30th June 2021

4:35 pm | Live Presenter Q&A

3:20 pm | Reimagining Druggability using Chemoproteomic Platforms

Kevin Foley
Chief Scientific Officer
Ranok Therapeutics Co. Ltd.

Day One

Wednesday 30th June 2021

9:00 am | Panel Discussion: Advancing the Discovery of Proximity-Based Medicines

12:20 pm | Live Presenter Q&A

8:50 am | Chair’s Opening Remarks

Fleur Ferguson
Assistant Professor
University of California, San Diego

Day One

Wednesday 30th June 2021

4:35 pm | Live Presenter Q&A

3:45 pm | Chemoproteomic Approaches to Interrogate the Degradable Kinome

George Burslem
Assistant Professor
University of Pennsylvania

Day Two

Thursday 1st July 2021

4:20 pm | Live Presenter Q&A

3:30 pm | Chemical Approaches for Modulating Lysine Post-Translational Modifications: Ubiquitin and Beyond

Ivan Dikic
Director of Institute of Biochemistry II
Goethe University Frankfurst

Day Two

Thursday 1st July 2021

9:25 am | Future Challenges in the Proximity-Inducing Drugs (ProxiDrugs) Field

9:50 am | Live Presenter Q&A

Katherine Donovan
Senior Scientist
Dana-Farber Cancer Institute

Day One

Wednesday 30th June 2021

9:00 am | Panel Discussion: Advancing the Discovery of Proximity-Based Medicines

Christian Ottmann
Chief Technology Officer
Ambagon Therapeutics

Day Two

Thursday 1st July 2021

9:00 am | Small-Molecule Stabilization of 14-3-3 Protein-Protein Interactions

5:10 pm | Live Presenter Q&A

9:50 am | Live Presenter Q&A

Amit Chouhdary
Assistant Professor
Broad Institute, Harvard Medical School & Brigham and Women’s Hospital

Day Two

Thursday 1st July 2021

4:20 pm | Live Presenter Q&A

Ashley Modell
Postdoctoral Researcher, Choudhary Lab
Broad Institute of MIT and Harvard, and Harvard Medical School

Day Two

Thursday 1st July 2021

4:20 pm | Live Presenter Q&A

3:55 pm | Rewiring Kinases Using Bifunctional Molecules

Carla Gauss
Senior Application Scientist, Medicinal Chemist
Nanome

Day One

Wednesday 30th June 2021

2:30 pm | Designed Degraders of PCSK9 in Nanome

2:45 pm | Live Presenter Q&A

Dirksen E. Bussiere
Sr. Director, Molecular Pharmacology
Eli Lilly and Company

Day One

Wednesday 30th June 2021

4:10 pm | The Structural Basis of Indisulam-Mediated Recruitment of RBM39 to the DCAF15-DDB1-DDA1 E3 Ligase Complex

4:35 pm | Live Presenter Q&A

Danette Daniels
Group Leader - Functional Proteomics
Promega

William Marsiglia
PostDoc
Icahn School of Medicine at Mount Sinai